(Q38126419)

29 August 2017

Cardiovascular safety of stimulants in children: findings from recent population-based cohort studies (English)

1 reference

29 August 2017

Almut G Winterstein

1

0 references

language of work or name

English

0 references

publication date

1 August 2013

1 reference

Current Psychiatry Reports

29 August 2017

1 reference

29 August 2017

15

1 reference

29 August 2017

8

1 reference

29 August 2017

379

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-013-0379-y

29 August 2017

0 references

cites work

ADHD drugs and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Short-term cardiovascular effects of methylphenidate and adderall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Phenylpropanolamine and the risk of hemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Cardiovascular events and death in children exposed and unexposed to ADHD agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

ADHD drugs and serious cardiovascular events in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Tachycardia-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-013-0379-Y

[Tachycardia-induced cardiomyopathy in children: a difficult diagnosis but a reversible form of left ventricular dysfunction]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23913135

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23913135

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23913135

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11920-013-0379-Y

1 reference

PubMed ID

23913135

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23913135